GTG Ann: GeneType Outperforms Traditional Risk Assessments - 29th Sep 2022, 8:08am

annb0t

annb0t

Top 20
GTG Ann: GeneType Outperforms Traditional Risk Assessments
Price Sensitive: Y
Date: 29th Sep 2022, 8:08am

>>> Read announcement: Google: GTG Market Announcements
 
You must log in or register to reply here.

Similar threads

annb0t
GTG Ann: geneType Granted Approval for 3 New Diseases in Australia - 11th Sep 2023, 8:31am
Replies
0
Views
60
annb0t
annb0t
annb0t
GTG Ann: Publication Validates geneType for Melanoma Risk Assessment - 28th Apr 2023, 9:02am
Replies
0
Views
104
annb0t
annb0t
annb0t
GTG Ann: Publication Validates geneType Prostate Cancer Risk Test - 19th Apr 2023, 9:22am
Replies
0
Views
109
annb0t
annb0t
annb0t
GTG Ann: GeneType MultiTest Panel Expanded Inclusion of New Diseases - 27th Mar 2023, 9:52am
Replies
0
Views
132
annb0t
annb0t
annb0t
GTG Ann: Further Study Validates geneType Breast Cancer Risk Test - 13th Mar 2023, 9:22am
Replies
0
Views
145
annb0t
annb0t
Top Bottom